tradingkey.logo
tradingkey.logo
Search

Cryoport Inc

CYRX
Add to Watchlist
15.960USD
+0.410+2.64%
Close 09-14 16:00ET
808.86MMarket Cap
11.15P/E TTM

More Details of Cryoport Inc Company

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

Cryoport Inc Profile

Ticker SymbolCYRX
Company nameCryoport Inc
IPO dateJul 24, 2015
CEOShelton (Jerrell Wilson)
Number of employees1090
Security typeOrdinary Share
Fiscal year-endJul 24
Address112 Westwood Place, Suite 350
CityBRENTWOOD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code37027
Phone19492321900
Websitehttps://www.cryoport.com/
Ticker SymbolCYRX
IPO dateJul 24, 2015
CEOShelton (Jerrell Wilson)

Company Executives of Cryoport Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
61.63K
+16.80%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
61.63K
+16.80%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
61.63K
+16.80%
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer, Treasurer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%

FAQs

Who are the top five shareholders of Cryoport Inc?

The top five shareholders of Cryoport Inc are: Mr. Daniel M. (Dan) Hancock

How many institutions hold shares of Cryoport Inc (CYRX)?

As of 2026Q1, 382 institutions hold shares of Cryoport Inc, with a combined market value of approximately 49.22M, accounting for 97.68% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -11194831.00.

What is the biggest source of revenue for Cryoport Inc?

In 2026Q1, the BioLogistics solutions business generated the highest revenue for Cryoport Inc, amounting to 22.36M and accounting for 45.66% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.